Phenox SA
The score of Phenox shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +73 % Total assets +62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phenox's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 116,737 € | ||||
| Equity | 421,366 € | ||||
| Cash | 452,515 € | ||||
| EBITDA | 203,924 € | ||||
| Total assets | 887,046 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Phenox's financial analysis
- Solvency47.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phenox
Phenox's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0883.995.840
- VAT number
- BE0883995840
- Peppol
- Registered · 0208:0883995840 · as of 05 Nov 2026
- Legal form
- SA
- Incorporated
- 02 Oct 2006
- Registered office
- 3090 Overijse
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Phenox (SA) has been based in Overijse since 2006, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 116,737 € and equity of 421,366 €; its revenue is not published. Its solvency stands at 47.5%, above the median of its sector (46.0%).
Companies similar to Phenox
Companies in the same business, of comparable size and area, outside its group.
- Bescan Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet 528,845 €
- Meditron Wholesale of pharmaceutical and medical goods Sint-Gillis-Waas · balance sheet 488,085 €
- Euro Medical Wholesale of pharmaceutical and medical goods Burdinne · balance sheet 807,168 €
- ALL Products Wholesale of pharmaceutical and medical goods Aalst · balance sheet 972,749 €
- Mobimed Wholesale of pharmaceutical and medical goods Roeselare · balance sheet 600,671 €
- H.D.P. Medical Wholesale of pharmaceutical and medical goods Waasmunster · balance sheet €1.32m
- AT - Medicals Wholesale of pharmaceutical and medical goods Hulshout · balance sheet €1.38m
- Urservices Wholesale of pharmaceutical and medical goods Zottegem · balance sheet 570,973 €
Frequently asked questions about Phenox
What is the revenue of Phenox?
Phenox files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phenox?
In Belgium, the VAT number is the company number prefixed with BE: BE0883995840 for Phenox, if the company is VAT-registered. Its company number (CBE) is 0883.995.840.
Where is the registered office of Phenox?
According to the CBE register, the registered office of Phenox is in 3090 Overijse.
What is the equity of Phenox?
At the close of the 2025 financial year, the equity of Phenox amounts to 421,366 €, a solvency of 47.5% of total assets.
Who manages Phenox?
The register lists 1 active mandates at Phenox. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phenox
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →